Literature DB >> 25397425

Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification.

Jean Ruelle1, Vasilieios Yfantis1, Armelle Duquenne1, Patrick Goubau1.   

Abstract

INTRODUCTION: Low or undetectable plasma viral load (VL) using current qPCR assays is common for HIV-2 patients. Digital PCR is an emerging technology enabling more precision and reproducibility than qPCR at low DNA/RNA copy numbers. Available data related to digital droplet PCR (ddPCR, Bio-Rad) underscore issues linked to the threshold definition of positivity, coupled to the specificity of low copy results (1).
MATERIALS AND METHODS: A RT-PCR protocol was set up using the One-Step RT-ddPCR Kit for Probes on the QX200 platform (Bio-Rad, Hercules, CA) in an accredited environment (ISO15189:2012 norm). Parameters tested were in line with the digital MIQE guidelines (2). Inter-run coefficient of variation (CV) was established using synthetic RNA controls diluted in HIV-negative plasma. The ddPCR assay was compared to a qRT-PCR previously used in routine (LOQ 50 cop/mL (3)) using 46 clinical samples and the NIBSC international HIV-2 RNA standard.
RESULTS: The optimal PCR efficiency and the best separation between positive and negative droplets were obtained with a mixture containing 0.5 mM manganese acetate, 700 nM primers and 250 nM of the 5'FAM-probe. Using a manual threshold to define positivity, 7.74% of negative controls (n=168) were scored as positive due to one positive droplet. The presence of two positive droplets or more was not observed for negative controls. Serial dilutions of a positive control showed excellent linearity (R2=0.999) and enabled us to define a limit of quantification of two positives droplets, which corresponds to 0.14 copies/μL in the reaction mixture and to seven copies per mL of plasma. The inter-run coefficient of variation was 3.37% at a mean value of 4,468 cop/mL, 19.59% at 416 cop/mL and 32.28% at 8 cop/mL. The NIBSC standard of 1,000 IU was quantified 1,400 copies by ddPCR and close to 5,000 copies by qPCR (delta log superior to 0.5). Among 46 clinical samples, 22 were undetectable with both qPCR and ddPCR, 12 were detected with both methods (respective means of 10,612 and 2,224 cop/mL, delta log=0.68) and 12 others were quantified by ddPCR only below 50 cop/mL (mean=16 cop/mL).
CONCLUSIONS: We validated a ddPCR HIV-2 VL assay that is more sensitive and more reproducible than the qPCR assay used as comparator, with a limit of quantification of 7 cop/mL of plasma. A careful definition of the limit of blank allows the management of false positive droplets, but the variable user-defined positive threshold may be an issue for compliance to the quality norms.

Entities:  

Year:  2014        PMID: 25397425      PMCID: PMC4225411          DOI: 10.7448/IAS.17.4.19675

Source DB:  PubMed          Journal:  J Int AIDS Soc        ISSN: 1758-2652            Impact factor:   5.396


  3 in total

1.  The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments.

Authors:  Jim F Huggett; Carole A Foy; Vladimir Benes; Kerry Emslie; Jeremy A Garson; Ross Haynes; Jan Hellemans; Mikael Kubista; Reinhold D Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer; Stephen A Bustin
Journal:  Clin Chem       Date:  2013-04-09       Impact factor: 8.327

2.  Quantitative real-time PCR on Lightcycler for the detection of human immunodeficiency virus type 2 (HIV-2).

Authors:  Jean Ruelle; Benoît Kabamba Mukadi; Martin Schutten; Patrick Goubau
Journal:  J Virol Methods       Date:  2004-04       Impact factor: 2.014

3.  Highly precise measurement of HIV DNA by droplet digital PCR.

Authors:  Matthew C Strain; Steven M Lada; Tiffany Luong; Steffney E Rought; Sara Gianella; Valeri H Terry; Celsa A Spina; Christopher H Woelk; Douglas D Richman
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  3 in total
  12 in total

1.  Randomized clinical trial: Combination antiretroviral therapy with tenofovir-emtricitabine and lopinavir-ritonavir in patients with primary biliary cholangitis.

Authors:  Ellina Lytvyak; Ishwar Hosamani; Aldo J Montano-Loza; Lynora Saxinger; Andrew L Mason
Journal:  Can Liver J       Date:  2019-01-09

Review 2.  Droplet microfluidics for high-sensitivity and high-throughput detection and screening of disease biomarkers.

Authors:  Aniruddha M Kaushik; Kuangwen Hsieh; Tza-Huei Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-05-24

3.  Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon.

Authors:  Emilande Guichet; Avelin Aghokeng; Sabrina Eymard-Duvernay; Nicole Vidal; Ahidjo Ayouba; Eitel Mpoudi Ngole; Eric Delaporte; Laura Ciaffi; Martine Peeters
Journal:  J Virol Methods       Date:  2016-09-05       Impact factor: 2.014

4.  Assessing the Variability of Cell-Associated HIV DNA Quantification through a Multicenter Collaborative Study.

Authors:  Yann Le Duff; Kathleen Gärtner; Eloise J Busby; Annalisa Dalzini; Sivapragashini Danaviah; José Luis Jiménez Fuentes; Carlo Giaquinto; Jim F Huggett; Matthew Hurley; Anne-Geneviève Marcellin; María Ángeles Muñoz-Fernández; Denise M O'Sullivan; Deborah Persaud; Laura Powell; Peter Rigsby; Paolo Rossi; Anita de Rossi; Lilly Siems; Theresa Smit; Sarah A Watters; Neil Almond; Eleni Nastouli
Journal:  Microbiol Spectr       Date:  2022-06-06

5.  Comparison of digital PCR platforms and semi-nested qPCR as a tool to determine the size of the HIV reservoir.

Authors:  K J Bosman; M Nijhuis; P M van Ham; A M J Wensing; K Vervisch; L Vandekerckhove; W De Spiegelaere
Journal:  Sci Rep       Date:  2015-09-09       Impact factor: 4.379

6.  Diagnostic utility of droplet digital PCR for HIV reservoir quantification.

Authors:  Wim Trypsteen; Maja Kiselinova; Linos Vandekerckhove; Ward De Spiegelaere
Journal:  J Virus Erad       Date:  2016-07-01

7.  Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.

Authors:  Joost H van Ginkel; Manon M H Huibers; Robert J J van Es; Remco de Bree; Stefan M Willems
Journal:  BMC Cancer       Date:  2017-06-19       Impact factor: 4.430

8.  CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection.

Authors:  Marcus Buggert; Juliet Frederiksen; Ole Lund; Michael R Betts; Antonio Biague; Morten Nielsen; Johanna Tauriainen; Hans Norrgren; Patrik Medstrand; Annika C Karlsson; Marianne Jansson
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

9.  Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.

Authors:  François E Dufrasne; Catherine Lombard; Patrick Goubau; Jean Ruelle
Journal:  Viruses       Date:  2016-10-14       Impact factor: 5.048

Review 10.  Application of droplet digital PCR to detect the pathogens of infectious diseases.

Authors:  Haiyi Li; Ruolan Bai; Zhenyu Zhao; Lvyan Tao; Mingbiao Ma; Zhenhua Ji; Miaomiao Jian; Zhe Ding; Xiting Dai; Fukai Bao; Aihua Liu
Journal:  Biosci Rep       Date:  2018-11-15       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.